Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00668746 · ClinicalTrials.gov registry record · Phase 4
Long-term Safety of Minocycline in Patients With Gum Disease
A Phase 4 study, sponsored by OraPharma.
- Completed
- Registry status
- Phase 4
- Development phase
- 35
- Enrollment target
NCT00668746 is a Phase 4 study that has completed, run by OraPharma. The registered enrollment target is 35 participants.
The verdict
NCT00668746, a Phase 4 study, has completed, sponsored by OraPharma.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 35 participants
- Enrollment target
Study Summary
This study will look at the safety of using the study medicine for a long time. It will see if the germs get used to the medicine, making it not work as well, if it's used by people with gum disease for a long time.
Interventions
- DRUG Minocycline HCl microspheres
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2007-12 |
| Est. Completion | 2009-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00668746
The ClinicalTrials.gov registry entry for NCT00668746 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OraPharma, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Minocycline HCl microspheres is the first listed.
NCT00668746 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00668746 about?
NCT00668746 is a clinical study titled "Long-term Safety of Minocycline in Patients With Gum Disease". This study will look at the safety of using the study medicine for a long time. It will see if the germs get used to the medicine, making it not work as well, if it's used by people with gum disease for a long time.
What is the current status of trial NCT00668746?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2007-12. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00668746?
The interventions under investigation include: Minocycline HCl microspheres (DRUG).
Who is sponsoring clinical trial NCT00668746?
This trial is sponsored by OraPharma, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.